↑ 薬物リストへ　← 戻る

Procedure: control group    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
34神経線維腫症1

34. 神経線維腫症　［臨床試験数：120，薬物数：182（DrugBank：72），標的遺伝子数：84，標的パスウェイ数：194］
Searched query = "Neurofibromatosis", "NF1", "von Recklinghausen disease", "NF2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 120 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02718131
(ClinicalTrials.gov)		March 20167/3/2016A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)NF1;Congenital Pseudarthrosis of TibiaDevice: INFUSE Bone Graft (BMP-2);Procedure: Control GroupUniversity of Alabama at BirminghamThe Children's Tumor Foundation;MedtronicActive, not recruiting2 Years18 YearsAll54N/AUnited States;Australia